🕵️ Serina Therapeutics, Inc. ($SER)
SEC insider & ownership activity, last 12 months · CIK 1708599 · every row links its SEC filing
Over the last 12 months insiders sold $912K against $78K of open-market buying. Moreadith Randall sold $912K through a 10b5-1 trading plan in 35 lots (Aug–Mar). One red-flag 8-K in the window: Delisting notice (3.01), Jan 9, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
4 buyers, $78K (7 lots) · 1 seller, $912K (35 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Moreadith Randall | 0 | – | 35 | $912K | Mar 23, 2026 |
| Karen J. Wilson | 4 | $55K | 0 | – | Jun 12, 2026 |
| Marshall Richard Peter | 1 | $20K | 0 | – | May 19, 2026 |
| Stephen K. Brannan | 1 | $2K | 0 | – | Jul 7, 2026 |
| Venkatesan Jay | 1 | $1K | 0 | – | May 22, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Juvventures (UK) Limited | 27.3% | 13D | Mar 20, 2026 | filing ↗ | |
| Juvenescence Limited | 27.3% | 13D | Mar 20, 2026 | filing ↗ | |
| SIO Capital Management, LLC | 6.7% | 13G | May 4, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Moreadith Randall | $279K | Jan 20, 2026 | filing ↗ |
| Moreadith Randall | $530K | Oct 13, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 19, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 17, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 15, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 15, 2026 | filing ↗ |
| Earnings (2.02) | Mar 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 25, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 17, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 17, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing ↗ |
| Other events (8.01) | Jan 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 27, 2026 | filing ↗ |
| Delisting notice (3.01) | Jan 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 9, 2026 | filing ↗ |
| Other events (8.01) | Dec 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 10, 2025 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Shareholder vote (5.07) | Nov 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 7, 2025 | filing ↗ |
| Other events (8.01) | Nov 3, 2025 | filing ↗ |
| Other events (8.01) | Oct 6, 2025 | filing ↗ |